Baolingbao Biology Co Ltd
SZSE:002286
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Baolingbao Biology Co Ltd
Operating Income
Baolingbao Biology Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Baolingbao Biology Co Ltd
SZSE:002286
|
Operating Income
¥193.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
36%
|
|
|
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
|
Operating Income
¥9.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
|
|
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
|
Operating Income
¥8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
|
Operating Income
¥1.7B
|
CAGR 3-Years
-39%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Muyuan Foods Co Ltd
SZSE:002714
|
Operating Income
¥13.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
29%
|
|
|
Wens Foodstuff Group Co Ltd
SZSE:300498
|
Operating Income
¥2.9B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-11%
|
|
Baolingbao Biology Co Ltd
Glance View
Baolingbao Biology Co., Ltd. engages in the manufacture of corn-based health and food ingredients. The company is headquartered in Dezhou, Shandong and currently employs 1,321 full-time employees. The company went IPO on 2009-08-11. The firm mainly provides oligosaccharide series, sugar alcohol series, high fructose syrup series, other starch sugar series, as well as starch and byproducts. The firm distributes its products in domestic markets and to overseas markets.
See Also
What is Baolingbao Biology Co Ltd's Operating Income?
Operating Income
193.3m
CNY
Based on the financial report for Sep 30, 2025, Baolingbao Biology Co Ltd's Operating Income amounts to 193.3m CNY.
What is Baolingbao Biology Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
36%
Over the last year, the Operating Income growth was 43%. The average annual Operating Income growth rates for Baolingbao Biology Co Ltd have been 2% over the past three years , 21% over the past five years , and 36% over the past ten years .
